Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort
Journal of Cystic Fibrosis · 2026
DOI: 10.1016/j.jcf.2026.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Esben Herborg Henriksen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Cystic Fibrosis Center Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Pediatr…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Bone Density, Quinolones, Aminophenols. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Malnutrition, inflammation, limited exercise, and low muscle mass increase the risk of cystic fibrosis (CF) bone disease (CFBD). Additionally, dysfunction of the CF transmembrane conductance regulator (CFTR) directly affects bone-forming cells. Elexacaftor/Tezacaftor/Ivacaftor (ETI) could influence these aspects. We examined the impact of ETI on bone health in Danish people with CF. METHODS: This nationwide cohort study evaluated changes in bone status in adults with CF after ETI treatment. Dual energy X-ray absorptiometry (DXA) was used to assess bone mineral density Z-scores in lumbar spine, femoral neck, and total hip. To assess calcium metabolism, plasma levels of vitamin D, calcium, and parathyroid hormone (PTH) were evaluated. Data were collected from 2 years pre- to 3.5 years post-ETI initiation, comparing pre-ETI levels with 1-, 2- and 3-year post-ETI measurements. Data were analyzed using linear mixed effects regression models and subgroup interaction analyses. RESULTS: 197 Danish adults with CF were included in the study, contributing 435 DXA scans. Mean change from pre-ETI period (95%CI) in femoral neck and total hip Z-scores showed a decrease by year 3 of -0.16 (-0.31; -0.01; p=0.04) and -0.15 (-0.30;
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Cystic Fibrosis Center Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshosp…
- Department of Infectious Diseases, Cystic Fibrosis Center Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Copenhagen Phase IV Unit, Department of Clinical Pharmacology and Center for Clinical Research and Prevention, University Hospital of Copenhagen - Bispebjerg and Frederiksberg, DK, Denmark.
- Department of Infectious Diseases, Cystic Fibrosis Center Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
- Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Zitieren
APA
Henriksen, E. H., Nielsen, B. U., Jensen, C. B., Bryrup, T., Dahl, C. H., Bader-Larsen, K., Leo-Hansen, C., Olsen, M. F., Jeppesen, M., Oturai, P., Schwarz, P., Langdahl, B., Almdal, T., Faurholt-Jepsen, D., Mathiesen, I. H. M., & TransformCF Study Group (2026). Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.02.002
Vancouver
Henriksen EH, Nielsen BU, Jensen CB, Bryrup T, Dahl CH, Bader-Larsen K, et al. Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.02.002
BibTeX
@article{Henriksen2026,
author = {Henriksen, Esben Herborg and Nielsen, Bibi Uhre and Jensen, Camilla Bjørn and Bryrup, Thomas and Dahl, Christine Højte and Bader-Larsen, Karlen and Leo-Hansen, Christian and Olsen, Mette Frahm and Jeppesen, Majbritt and Oturai, Peter and Schwarz, Peter and Langdahl, Bente and Almdal, Thomas and Faurholt-Jepsen, Daniel and Mathiesen, Inger Hee Mabuza and TransformCF Study Group, TransformCF Study Group},
title = {Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort},
journal = {Journal of Cystic Fibrosis},
year = {2026},
doi = {10.1016/j.jcf.2026.02.002}
}
EUVIMED